Diabetes Pharmacist : Diabetes Pharmacist Blog : Focus Express Mail Pharmacy : Insulin Pumps, Diabetes Supplies and Information

The staff at Focus Pharmacy speak to people with Diabetes all day. Lately, I hear, they've been getting a lot of "Where have you been all my life?" and "THANK YOU for being there for us"  from new customers. And some "We couldn't afford our medications and supplies if it wasn't for you, thanks!" from long time customers.  Just wanted to let those who don't know about Focus Pharmacy that:

• They stock all brands of insulin pump supplies including Medtronic,Omnipod, & Accu-Check
• They accept the insurance payment as payment in full (where allowed)
     so you have NO COPAYS To Pay
• Insurance claims and billings are handled by them - no paperwork for you.
• FREE overnight shipping of all your medications (they are a full service pharmacy too) and supplies.
• A live person will always answer your phone calls M-F, 9-5 ET 
• You can order your refills on-line anytime
• A pharmacist is available for emergencies 24 hours a day, 7 days a week
• They guarantee 100% satisfaction.
•  No Membership or Hidden Fees Ever
• If your insurance, qualifies, you get a $50 gift card with your first order!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

According to a recent study of people with Type 2 Diabetes, among high insulin users (using more than 150 units daily) insulin pump delivery  saved more than $12,000 over 4 years vs.Multiple Daily Injections (MDI) because basal rates dropped dramatically owing to better insulin absorption said certified diabetes educatorPhyllis Wolff-McDonagh, DNP, at the annual meeting of the American Association of Diabetes Educators.

 MDI were significantly more expensive than pump therapy for the high insulin user  patients: $41,100 vs. $28,826. With the potential cost savings from improved glycemic control factored in, insulin pumps could also prove cost savings even for the moderate-use group, Dr. Wolff-McDonagh pointed out. Cost calculations included both supplies (syringes or pen needles, pump plus pump supplies) and the insulin.

• Email This
• Print
• Comments
• Trackbacks
• Share Link

According to researcher Marie L. Misso, PhD, of the Australasian Cochrane Center at Monash University, Clayton, Australia, "good evidence is now available to support the use of continuous subcutaneous insulin infusion in the appropriate patient."

To assess and compare the effects of continuous subcutaneous insulin infusion with multiple insulin injections, researchers studied 23 randomized controlled trials which included a total of 973 patients who used one of the two interventions for their type 1 diabetes. Results showed that  the continuous subcutaneous insulin infusion users (users of insulin pumps)  had significantly lower HbA1c levels compared with multiple insulin injection users.

For more information about insulin pumps, click here!

• Email This
• Print
• Comments
• Trackbacks
• Share Link